Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi PharmaTech’s Facility Receives GLP Certificate | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi PharmaTech’s Facility Receives GLP Certificate

Expands capabilities for non-clinical lab studies under SFDA

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech’s toxicology facility in Suzhou has received a GLP certificate from the State Food and Drug Administration (SFDA) of the People’s Republic of China after successfully passing two inspections. Having assessed its processes and conditions under which studies are planned, performed, monitored, recorded, archived, and reported, the GLP certificate acknowledges the facility’s capacity to perform non-clinical lab studies under SFDA GLP regulations.
 
The inspection included an audit of 16 studies in areas that included reproductive toxicology, carcinogenicity, safety pharmacology, dermal irritation, skin phototoxicity, vascular irritation, and immunology. The inspection also evaluated key operational sites, including the vivarium rooms, pharmacy, central archive, and labs relating to analytical chemistry, bioanalytical services, toxicokinetics, clinical pathology, histopathology, and immunology. 
 
“WuXi’s receipt of this certificate is further acknowledgment that we offer our clients non-clinical laboratory studies that meet national and international GLP quality standards,” said Edward Hu, chief operating officer and chief financial officer of WuXi PharmaTech. “This award is additional confirmation of WuXi’s capability in offering our pharmaceutical and biotech clients a comprehensive, fully integrated platform of pharmaceutical R&D services.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics